| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Kevin G Byrnes last filed a Form 4 in November 2021, as Director at MED. Kevin G Byrnes's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 14,922 shares of MED. The MED filings lean toward selling, a net 673 shares.
Kevin G Byrnes has 10 Form 4 filings on record from February 2015 to November 2021, all as Director at Medifast (MED), 2015–2021.
The 15 reported transactions were 7 stock awards, 3 option exercises, 2 option or other derivative awards and 1 tax withholding, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $149K.
The only open-market sale was 673 shares of MED at an average $221.99 on August 20, 2021, about $149K. Twelve months later MED was down 38%.
Shares as reported in the last Form 4 for each company; the most recent is from November 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2021 | MED Medifast Inc | Director | Sell | 673 | $221.99 | $149,399.27 | -7.6% | -1.4% | -37.6% |